0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Human Rabies Vaccine Market Report & Forecast 2023-2029
Published Date: December 2023
|
Report Code: QYRE-Auto-11U16262
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global and India Human Rabies Vaccine Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Human Rabies Vaccine Market Report & Forecast 2023-2029

Code: QYRE-Auto-11U16262
Report
December 2023
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

and India Human Rabies Vaccine Market Size

The global Human Rabies Vaccine revenue was US$ 1056 million in 2022 and is forecast to a readjusted size of US$ 1422.9 million by 2029 with a CAGR of 4.3% during the forecast period (2023-2029).

and India Human Rabies Vaccine Market

and India Human Rabies Vaccine Market

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
In India, the Human Rabies Vaccine revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.
Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.
The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.
Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 70% of the share.
This report focuses on global and India Human Rabies Vaccine market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Human Rabies Vaccine will continue to grow rapidly in the future.
Global Human Rabies Vaccine Scope and Market Size
Human Rabies Vaccine market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Human Rabies Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Human Rabies Vaccine market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Human Rabies Vaccine Market Report

Report Metric Details
Report Name and India Human Rabies Vaccine Market
Forecasted market size in 2029 US$ 1422.9 million
CAGR 4.3%
Forecasted years 2023 - 2029
Segment by Type
  • Vero Cell
  • BHK
  • Chick Embryo Cell
  • Human Diploid Cells
  • Others
Segment by Application
  • Pre-Exposure Vaccine
  • Post-Exposure Vaccine
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological, ZhongKe Biopharm, Ningbo Rongan Biological, Indian Immunologicals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Human Rabies Vaccine Market size in 2029?

Ans: The and India Human Rabies Vaccine Market size in 2029 will be US$ 1422.9 million.

What is the and India Human Rabies Vaccine Market share by region?

Ans: Besides, North Americas is the second largest consumption area with a consumption market share of over 15%. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

What is the and India Human Rabies Vaccine Market share by type?

Ans: In addition, the proportion of Vero Cell rabies vaccines is about 85%.

Who are the main players in the and India Human Rabies Vaccine Market report?

Ans: The main players in the and India Human Rabies Vaccine Market are Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological, ZhongKe Biopharm, Ningbo Rongan Biological, Indian Immunologicals

What are the Application segmentation covered in the and India Human Rabies Vaccine Market report?

Ans: The Applications covered in the and India Human Rabies Vaccine Market report are Pre-Exposure Vaccine, Post-Exposure Vaccine

What are the Type segmentation covered in the and India Human Rabies Vaccine Market report?

Ans: The Types covered in the and India Human Rabies Vaccine Market report are Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, Others

Recommended Reports

Human Rabies Vaccines

Vaccine Technologies

Other Human Vaccines

1 Study Coverage
1.1 Human Rabies Vaccine Product Introduction
1.2 Global Human Rabies Vaccine Outlook 2018 VS 2022 VS 2029
1.2.1 Global Human Rabies Vaccine Sales in US$ Million for the Year 2018-2029
1.2.2 Global Human Rabies Vaccine Sales in Volume for the Year 2018-2029
1.3 India Human Rabies Vaccine Outlook 2018 VS 2022 VS 2029
1.3.1 India Human Rabies Vaccine Sales in US$ Million for the Year 2018-2029
1.3.2 India Human Rabies Vaccine Sales in Volume for the Year 2018-2029
1.4 Human Rabies Vaccine Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Human Rabies Vaccine in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Human Rabies Vaccine Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Human Rabies Vaccine Market Dynamics
1.5.1 Human Rabies Vaccine Industry Trends
1.5.2 Human Rabies Vaccine Market Drivers
1.5.3 Human Rabies Vaccine Market Challenges
1.5.4 Human Rabies Vaccine Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Human Rabies Vaccine by Type
2.1 Human Rabies Vaccine Market Segment by Type
2.1.1 Vero Cell
2.1.2 BHK
2.1.3 Chick Embryo Cell
2.1.4 Human Diploid Cells
2.1.5 Others
2.2 Global Human Rabies Vaccine Market Size by Type
2.2.1 Global Human Rabies Vaccine Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Human Rabies Vaccine Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Human Rabies Vaccine Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Human Rabies Vaccine Market Size by Type
2.3.1 India Human Rabies Vaccine Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Human Rabies Vaccine Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Human Rabies Vaccine Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Human Rabies Vaccine by Application
3.1 Human Rabies Vaccine Market Segment by Application
3.1.1 Pre-Exposure Vaccine
3.1.2 Post-Exposure Vaccine
3.2 Global Human Rabies Vaccine Market Size by Application
3.2.1 Global Human Rabies Vaccine Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Human Rabies Vaccine Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Human Rabies Vaccine Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Human Rabies Vaccine Market Size by Application
3.3.1 India Human Rabies Vaccine Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Human Rabies Vaccine Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Human Rabies Vaccine Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Human Rabies Vaccine Competitor Landscape by Company
4.1 Global Human Rabies Vaccine Market Size by Company
4.1.1 Global Key Manufacturers of Human Rabies Vaccine, Ranked by Revenue (2022)
4.1.2 Global Human Rabies Vaccine Revenue by Manufacturer (2018-2023)
4.1.3 Global Human Rabies Vaccine Sales by Manufacturer (2018-2023)
4.1.4 Global Human Rabies Vaccine Price by Manufacturer (2018-2023)
4.2 Global Human Rabies Vaccine Concentration Ratio (CR)
4.2.1 Human Rabies Vaccine Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Human Rabies Vaccine in 2022
4.2.3 Global Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Human Rabies Vaccine, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Human Rabies Vaccine, Product Offered and Application
4.5 Global Key Manufacturers of Human Rabies Vaccine, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Human Rabies Vaccine Market Size by Company
4.7.1 Key Players of Human Rabies Vaccine in India, Ranked by Revenue (2022)
4.7.2 India Human Rabies Vaccine Revenue by Players (2018-2023)
4.7.3 India Human Rabies Vaccine Sales by Players (2018-2023)
5 Global Human Rabies Vaccine Market Size by Region
5.1 Global Human Rabies Vaccine Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Human Rabies Vaccine Market Size in Volume by Region (2018-2029)
5.2.1 Global Human Rabies Vaccine Sales in Volume by Region: 2018-2023
5.2.2 Global Human Rabies Vaccine Sales in Volume Forecast by Region (2024-2029)
5.3 Global Human Rabies Vaccine Market Size in Value by Region (2018-2029)
5.3.1 Global Human Rabies Vaccine Sales in Value by Region: 2018-2023
5.3.2 Global Human Rabies Vaccine Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Human Rabies Vaccine Market Size YoY Growth 2018-2029
6.2 Americas Human Rabies Vaccine Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Human Rabies Vaccine Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Human Rabies Vaccine Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Human Rabies Vaccine Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Human Rabies Vaccine Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Human Rabies Vaccine Market Size YoY Growth 2018-2029
7.2 EMEA Human Rabies Vaccine Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Human Rabies Vaccine Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Human Rabies Vaccine Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Human Rabies Vaccine Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Human Rabies Vaccine Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Human Rabies Vaccine Market Size YoY Growth 2018-2029
8.2 China Human Rabies Vaccine Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Human Rabies Vaccine Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Human Rabies Vaccine Market Size YoY Growth 2018-2029
9.2 APAC Human Rabies Vaccine Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Human Rabies Vaccine Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Human Rabies Vaccine Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Human Rabies Vaccine Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Human Rabies Vaccine Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Bharat Biotech
10.1.1 Bharat Biotech Company Information
10.1.2 Bharat Biotech Description and Business Overview
10.1.3 Bharat Biotech Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bharat Biotech Human Rabies Vaccine Products Offered
10.1.5 Bharat Biotech Recent Development
10.2 Bavarian Nordic
10.2.1 Bavarian Nordic Company Information
10.2.2 Bavarian Nordic Description and Business Overview
10.2.3 Bavarian Nordic Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bavarian Nordic Human Rabies Vaccine Products Offered
10.2.5 Bavarian Nordic Recent Development
10.3 Sanofi-Pasteur
10.3.1 Sanofi-Pasteur Company Information
10.3.2 Sanofi-Pasteur Description and Business Overview
10.3.3 Sanofi-Pasteur Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sanofi-Pasteur Human Rabies Vaccine Products Offered
10.3.5 Sanofi-Pasteur Recent Development
10.4 Chengda Bio
10.4.1 Chengda Bio Company Information
10.4.2 Chengda Bio Description and Business Overview
10.4.3 Chengda Bio Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Chengda Bio Human Rabies Vaccine Products Offered
10.4.5 Chengda Bio Recent Development
10.5 KANGH
10.5.1 KANGH Company Information
10.5.2 KANGH Description and Business Overview
10.5.3 KANGH Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 KANGH Human Rabies Vaccine Products Offered
10.5.5 KANGH Recent Development
10.6 Prcmise
10.6.1 Prcmise Company Information
10.6.2 Prcmise Description and Business Overview
10.6.3 Prcmise Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Prcmise Human Rabies Vaccine Products Offered
10.6.5 Prcmise Recent Development
10.7 Henan Grand Biopharma
10.7.1 Henan Grand Biopharma Company Information
10.7.2 Henan Grand Biopharma Description and Business Overview
10.7.3 Henan Grand Biopharma Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Henan Grand Biopharma Human Rabies Vaccine Products Offered
10.7.5 Henan Grand Biopharma Recent Development
10.8 Zhuoyi Biological
10.8.1 Zhuoyi Biological Company Information
10.8.2 Zhuoyi Biological Description and Business Overview
10.8.3 Zhuoyi Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Zhuoyi Biological Human Rabies Vaccine Products Offered
10.8.5 Zhuoyi Biological Recent Development
10.9 ZhongKe Biopharm
10.9.1 ZhongKe Biopharm Company Information
10.9.2 ZhongKe Biopharm Description and Business Overview
10.9.3 ZhongKe Biopharm Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 ZhongKe Biopharm Human Rabies Vaccine Products Offered
10.9.5 ZhongKe Biopharm Recent Development
10.10 Ningbo Rongan Biological
10.10.1 Ningbo Rongan Biological Company Information
10.10.2 Ningbo Rongan Biological Description and Business Overview
10.10.3 Ningbo Rongan Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Ningbo Rongan Biological Human Rabies Vaccine Products Offered
10.10.5 Ningbo Rongan Biological Recent Development
10.11 Indian Immunologicals
10.11.1 Indian Immunologicals Company Information
10.11.2 Indian Immunologicals Description and Business Overview
10.11.3 Indian Immunologicals Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Indian Immunologicals Human Rabies Vaccine Products Offered
10.11.5 Indian Immunologicals Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Human Rabies Vaccine Industry Chain Analysis
11.2 Human Rabies Vaccine Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Human Rabies Vaccine Production Mode & Process
11.4 Human Rabies Vaccine Sales and Marketing
11.4.1 Human Rabies Vaccine Sales Channels
11.4.2 Human Rabies Vaccine Distributors
11.5 Human Rabies Vaccine Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Human Rabies Vaccine CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. Human Rabies Vaccine Market Trends
    Table 3. Human Rabies Vaccine Market Drivers
    Table 4. Human Rabies Vaccine Market Challenges
    Table 5. Human Rabies Vaccine Market Restraints
    Table 6. Global Human Rabies Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Human Rabies Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Human Rabies Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Human Rabies Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Human Rabies Vaccine, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Human Rabies Vaccine Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Human Rabies Vaccine Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Human Rabies Vaccine Sales by Manufacturer, (K Units), 2018-2023
    Table 14. Global Human Rabies Vaccine Sales Share by Manufacturer, 2018-2023
    Table 15. Global Human Rabies Vaccine Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 16. Global Human Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Human Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Vaccine as of 2022)
    Table 18. Global Key Manufacturers of Human Rabies Vaccine, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Human Rabies Vaccine, Product Offered and Application
    Table 20. Global Key Manufacturers of Human Rabies Vaccine, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Human Rabies Vaccine in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India Human Rabies Vaccine Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India Human Rabies Vaccine Revenue Share by Players, (2018-2023)
    Table 25. India Human Rabies Vaccine Sales by Players, (K Units), (2018-2023)
    Table 26. India Human Rabies Vaccine Sales Share by Players, (2018-2023)
    Table 27. Global Human Rabies Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Human Rabies Vaccine Sales in Volume by Region (2018-2023) & (K Units)
    Table 29. Global Human Rabies Vaccine Sales in Volume Forecast by Region (2024-2029) & (K Units)
    Table 30. Global Human Rabies Vaccine Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Human Rabies Vaccine Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Human Rabies Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Human Rabies Vaccine Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Human Rabies Vaccine Sales in Volume by Country (2018-2023) & (K Units)
    Table 36. Americas Human Rabies Vaccine Sales in Volume by Country (2024-2029) & (K Units)
    Table 37. EMEA Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Human Rabies Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Human Rabies Vaccine Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Human Rabies Vaccine Sales in Volume by Country (2018-2023) & (K Units)
    Table 41. EMEA Human Rabies Vaccine Sales in Volume by Country (2024-2029) & (K Units)
    Table 42. APAC Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Human Rabies Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Human Rabies Vaccine Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Human Rabies Vaccine Sales in Volume by Country (2018-2023) & (K Units)
    Table 46. APAC Human Rabies Vaccine Sales in Volume by Country (2024-2029) & (K Units)
    Table 47. Bharat Biotech Company Information
    Table 48. Bharat Biotech Description and Business Overview
    Table 49. Bharat Biotech Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 50. Bharat Biotech Human Rabies Vaccine Product
    Table 51. Bharat Biotech Recent Development
    Table 52. Bavarian Nordic Company Information
    Table 53. Bavarian Nordic Description and Business Overview
    Table 54. Bavarian Nordic Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 55. Bavarian Nordic Human Rabies Vaccine Product
    Table 56. Bavarian Nordic Recent Development
    Table 57. Sanofi-Pasteur Company Information
    Table 58. Sanofi-Pasteur Description and Business Overview
    Table 59. Sanofi-Pasteur Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 60. Sanofi-Pasteur Human Rabies Vaccine Product
    Table 61. Sanofi-Pasteur Recent Development
    Table 62. Chengda Bio Company Information
    Table 63. Chengda Bio Description and Business Overview
    Table 64. Chengda Bio Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 65. Chengda Bio Human Rabies Vaccine Product
    Table 66. Chengda Bio Recent Development
    Table 67. KANGH Company Information
    Table 68. KANGH Description and Business Overview
    Table 69. KANGH Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 70. KANGH Human Rabies Vaccine Product
    Table 71. KANGH Recent Development
    Table 72. Prcmise Company Information
    Table 73. Prcmise Description and Business Overview
    Table 74. Prcmise Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 75. Prcmise Human Rabies Vaccine Product
    Table 76. Prcmise Recent Development
    Table 77. Henan Grand Biopharma Company Information
    Table 78. Henan Grand Biopharma Description and Business Overview
    Table 79. Henan Grand Biopharma Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 80. Henan Grand Biopharma Human Rabies Vaccine Product
    Table 81. Henan Grand Biopharma Recent Development
    Table 82. Zhuoyi Biological Company Information
    Table 83. Zhuoyi Biological Description and Business Overview
    Table 84. Zhuoyi Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 85. Zhuoyi Biological Human Rabies Vaccine Product
    Table 86. Zhuoyi Biological Recent Development
    Table 87. ZhongKe Biopharm Company Information
    Table 88. ZhongKe Biopharm Description and Business Overview
    Table 89. ZhongKe Biopharm Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 90. ZhongKe Biopharm Human Rabies Vaccine Product
    Table 91. ZhongKe Biopharm Recent Development
    Table 92. Ningbo Rongan Biological Company Information
    Table 93. Ningbo Rongan Biological Description and Business Overview
    Table 94. Ningbo Rongan Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 95. Ningbo Rongan Biological Human Rabies Vaccine Product
    Table 96. Ningbo Rongan Biological Recent Development
    Table 97. Indian Immunologicals Company Information
    Table 98. Indian Immunologicals Description and Business Overview
    Table 99. Indian Immunologicals Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 100. Indian Immunologicals Human Rabies Vaccine Product
    Table 101. Indian Immunologicals Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Human Rabies Vaccine Customers List
    Table 105. Human Rabies Vaccine Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Rabies Vaccine Product Picture
    Figure 2. Global Human Rabies Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Human Rabies Vaccine Market Size 2018-2029 (US$ Million)
    Figure 4. Global Human Rabies Vaccine Sales 2018-2029 (K Units)
    Figure 5. India Human Rabies Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India Human Rabies Vaccine Market Size 2018-2029 (US$ Million)
    Figure 7. India Human Rabies Vaccine Sales 2018-2029 (K Units)
    Figure 8. India Human Rabies Vaccine Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India Human Rabies Vaccine Market Share in Global, in Volume (K Units) 2018-2029
    Figure 10. Human Rabies Vaccine Report Years Considered
    Figure 11. Product Picture of Vero Cell
    Figure 12. Product Picture of BHK
    Figure 13. Product Picture of Chick Embryo Cell
    Figure 14. Product Picture of Human Diploid Cells
    Figure 15. Product Picture of Others
    Figure 16. Global Human Rabies Vaccine Market Share by Type in 2022 & 2029
    Figure 17. Global Human Rabies Vaccine Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 18. Global Human Rabies Vaccine Sales Market Share in Value by Type (2018-2029)
    Figure 19. Global Human Rabies Vaccine Sales by Type (2018-2029) & (K Units)
    Figure 20. Global Human Rabies Vaccine Sales Market Share in Volume by Type (2018-2029)
    Figure 21. Global Human Rabies Vaccine Price by Type (2018-2029) & (US$/Unit)
    Figure 22. India Human Rabies Vaccine Market Share by Type in 2022 & 2029
    Figure 23. India Human Rabies Vaccine Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 24. India Human Rabies Vaccine Sales Market Share in Value by Type (2018-2029)
    Figure 25. India Human Rabies Vaccine Sales by Type (2018-2029) & (K Units)
    Figure 26. India Human Rabies Vaccine Sales Market Share in Volume by Type (2018-2029)
    Figure 27. India Human Rabies Vaccine Price by Type (2018-2029) & (US$/Unit)
    Figure 28. Product Picture of Pre-Exposure Vaccine
    Figure 29. Product Picture of Post-Exposure Vaccine
    Figure 30. Global Human Rabies Vaccine Market Share by Application in 2022 & 2029
    Figure 31. Global Human Rabies Vaccine Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 32. Global Human Rabies Vaccine Sales Market Share in Value by Application (2018-2029)
    Figure 33. Global Human Rabies Vaccine Sales by Application (2018-2029) & (K Units)
    Figure 34. Global Human Rabies Vaccine Sales Market Share in Volume by Application (2018-2029)
    Figure 35. Global Human Rabies Vaccine Price by Application (2018-2029) & (US$/Unit)
    Figure 36. India Human Rabies Vaccine Market Share by Application in 2022 & 2029
    Figure 37. India Human Rabies Vaccine Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 38. India Human Rabies Vaccine Sales Market Share in Value by Application (2018-2029)
    Figure 39. India Human Rabies Vaccine Sales by Application (2018-2029) & (K Units)
    Figure 40. India Human Rabies Vaccine Sales Market Share in Volume by Application (2018-2029)
    Figure 41. India Human Rabies Vaccine Price by Application (2018-2029) & (US$/Unit)
    Figure 42. Americas Human Rabies Vaccine Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 43. Americas Human Rabies Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 44. Americas Human Rabies Vaccine Sales by Type (2018-2029) & (K Units)
    Figure 45. Americas Human Rabies Vaccine Sales Market Share in Volume by Type (2018-2029)
    Figure 46. Americas Human Rabies Vaccine Sales by Application (2018-2029) & (K Units)
    Figure 47. Americas Human Rabies Vaccine Sales Market Share in Volume by Application (2018-2029)
    Figure 48. United States Human Rabies Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Canada Human Rabies Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Mexico Human Rabies Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Brazil Human Rabies Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 52. EMEA Human Rabies Vaccine Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 53. EMEA Human Rabies Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 54. EMEA Human Rabies Vaccine Sales by Type (2018-2029) & (K Units)
    Figure 55. EMEA Human Rabies Vaccine Sales Market Share in Volume by Type (2018-2029)
    Figure 56. EMEA Human Rabies Vaccine Sales by Application (2018-2029) & (K Units)
    Figure 57. EMEA Human Rabies Vaccine Sales Market Share in Volume by Application (2018-2029)
    Figure 58. Europe Human Rabies Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 59. Middle East Human Rabies Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 60. Africa Human Rabies Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 61. China Human Rabies Vaccine Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 62. China Human Rabies Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 63. China Human Rabies Vaccine Sales by Type (2018-2029) & (K Units)
    Figure 64. China Human Rabies Vaccine Sales Market Share in Volume by Type (2018-2029)
    Figure 65. China Human Rabies Vaccine Sales by Application (2018-2029) & (K Units)
    Figure 66. China Human Rabies Vaccine Sales Market Share in Volume by Application (2018-2029)
    Figure 67. APAC Human Rabies Vaccine Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 68. APAC Human Rabies Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 69. APAC Human Rabies Vaccine Sales by Type (2018-2029) & (K Units)
    Figure 70. APAC Human Rabies Vaccine Sales Market Share in Volume by Type (2018-2029)
    Figure 71. APAC Human Rabies Vaccine Sales by Application (2018-2029) & (K Units)
    Figure 72. APAC Human Rabies Vaccine Sales Market Share in Volume by Application (2018-2029)
    Figure 73. Japan Human Rabies Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 74. South Korea Human Rabies Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. China Taiwan Human Rabies Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 76. Southeast Asia Human Rabies Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 77. India Human Rabies Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 78. Human Rabies Vaccine Value Chain
    Figure 79. Human Rabies Vaccine Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS